- Home
- AURA vs NLOP Comparison
AURA vs NLOP Comparison
Compare AURA & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- NLOP
- Stock Information
- Founded
- AURA 2007
- NLOP 2022
- Country
- AURA United States
- NLOP United States
- Employees
- AURA N/A
- NLOP N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- AURA Health Care
- NLOP
- Exchange
- AURA Nasdaq
- NLOP Nasdaq
- Market Cap
- AURA 438.3M
- NLOP 481.5M
- IPO Year
- AURA 2021
- NLOP N/A
- Fundamental
- Price
- AURA $8.34
- NLOP $31.23
- Analyst Decision
- AURA Strong Buy
- NLOP Strong Buy
- Analyst Count
- AURA 4
- NLOP 1
- Target Price
- AURA $23.00
- NLOP $46.00
- AVG Volume (30 Days)
- AURA 206.4K
- NLOP 61.1K
- Earning Date
- AURA 11-12-2024
- NLOP 01-01-0001
- Dividend Yield
- AURA N/A
- NLOP 1.04%
- EPS Growth
- AURA N/A
- NLOP N/A
- EPS
- AURA N/A
- NLOP N/A
- Revenue
- AURA N/A
- NLOP $160,911,000.00
- Revenue This Year
- AURA N/A
- NLOP N/A
- Revenue Next Year
- AURA N/A
- NLOP N/A
- P/E Ratio
- AURA N/A
- NLOP N/A
- Revenue Growth
- AURA N/A
- NLOP N/A
- 52 Week Low
- AURA $6.63
- NLOP $16.04
- 52 Week High
- AURA $12.38
- NLOP $33.06
- Technical
- Relative Strength Index (RSI)
- AURA 39.95
- NLOP 45.20
- Support Level
- AURA $8.30
- NLOP $31.75
- Resistance Level
- AURA $9.04
- NLOP $32.85
- Average True Range (ATR)
- AURA 0.46
- NLOP 0.80
- MACD
- AURA 0.01
- NLOP -0.07
- Stochastic Oscillator
- AURA 20.93
- NLOP 11.35
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a real estate investment trust. Through its subsidiaries it owns, operates, and finances office buildings. Its properties are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its portfolio includes approximately 1.5 million square feet of Green-Certified Buildings, 4 LEED-Certified Buildings, and 1 BREEAM-Certified Building.